OncoCyte Corporation (OCX)
NASDAQ: OCX
· Real-Time Price · USD
3.20
0.47 (17.22%)
At close: Jun 17, 2025, 3:59 PM
3.17
-0.94%
After-hours: Jun 17, 2025, 07:06 PM EDT
17.22% (1D)
| Bid | 2.62 |
| Market Cap | 91.52M |
| Revenue (ttm) | 3.84M |
| Net Income (ttm) | -58.2M |
| EPS (ttm) | -3.79 |
| PE Ratio (ttm) | -0.84 |
| Forward PE | -3.4 |
| Analyst | Buy |
| Ask | 3.3 |
| Volume | 100,557 |
| Avg. Volume (20D) | 76,061 |
| Open | 2.82 |
| Previous Close | 2.73 |
| Day's Range | 2.82 - 3.20 |
| 52-Week Range | 1.92 - 4.75 |
| Beta | 0.99 |
Analyst Forecast
According to 0 analyst ratings, the average rating for OCX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
OncoCyte Corporation is scheduled to release its earnings on Aug 7, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
7 months ago
-0.42%
Oncocyte Corp shares are trading higher after the ...
Unlock content with
Pro Subscription
